Miron Institute LLC – Trademark Portfolio
Entity Type: 16
Miron Institute LLC owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as OSOPIA, PRFEDU, NEXTGEN BIOMATERIALS, and ADVANCED PRF EDUCATION. Of these, 4 are registered. The portfolio spans 4 Nice Classification classes, led by Class 41 (Education & Entertainment) and Class 35 (Advertising & Business). Headquartered in VENICE, FL.
858 DAHOON CIRCLE
VENICE, FL 34293
Showing of trademarks Trademarks
Trademark Classifications
Miron Institute LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Miron Institute LLC have?
Miron Institute LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Miron Institute LLC file in?
Miron Institute LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Miron Institute LLC's most well-known trademarks?
Miron Institute LLC's registered trademark portfolio includes well-known marks such as OSOPIA, PRFEDU, NEXTGEN BIOMATERIALS, and ADVANCED PRF EDUCATION. These are among 4 currently registered trademarks in the portfolio.
What is Miron Institute LLC's trademark registration success rate?
Miron Institute LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.